21 results on '"Souza ASR"'
Search Results
2. Effects of Kinesio tape on vascularity, pliability and height of the hypertrophic scar in burns patients: a randomized pilot clinical trial.
- Author
-
Albuquerque AKB, de Lima CF, Lima Ribeiro E, Maia JN, de Sousa Rezende G, and Souza ASR
- Abstract
Deep burns damage the reticular dermis and may lead to the formation of hypertrophic scars. Compression therapy reduces local vascularity and realigns collagen fibers, resulting in esthetic and functional improvements. This study evaluated the effect of Kinesio tape compression with maximum mechanical tension on vascularity, pliability and the height of hypertrophic scars following deep burns. A single blind, randomized pilot clinical trial was carried out. The elastic compression of Kinesio tape was applied at maximum stretch in the intervention group (n=11) and no stretch in the sham group (n=11). Vascularity, pliability and height (the primary outcomes) were evaluated at 0, 45 and 90 days using the Vancouver Scar Scale (VSS). The association between the VSS scores, the intervention and the evaluation moment were analyzed using linear mixed-effects regression models, while comparisons of means between the groups were performed using the t Student test was. Significance was set at 5%. The mean VSS scores were similar between the groups. Significant improvement occurred in both groups when post-treatment and baseline scores were compared. No further improvement was found in the vascularity, pliability or height of hypertrophic scars resulting from deep burns when an elastic compression of Kinesio tape was used at maximum tension compared to lesser mechanical tension., (© The Author(s) 2024. Published by Oxford University Press on behalf of the American Burn Association. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
3. Evaluation of ovarian reserve in women with thyroid autoimmunity.
- Author
-
Notaro ALG, Lira Neto FT, Bedoschi GM, Silva MJD, Nunes MC, Monteiro CCP, Figueiroa JN, and Souza ASR
- Subjects
- Humans, Female, Adult, Retrospective Studies, Middle Aged, Young Adult, Autoantibodies blood, Adolescent, Thyroid Gland immunology, Ovarian Follicle, Ovarian Reserve physiology, Anti-Mullerian Hormone blood, Autoimmunity physiology
- Abstract
Objective: To compare the ovarian reserve of women of reproductive age with and without thyroid autoimmunity (TAI)., Methods: We performed a retrospective analysis of medical records from an assisted reproduction clinic from February 2017 to December 2021. Women aged between18 and 47 years with data on antithyroperoxidase and antithyroglobulin (anti-Tg) antibodies and assessment of ovarian reserve by anti-müllerian hormone (AMH) and antral follicle count (AFC) were included. Among the 188 participants included, 63 were diagnosed with TAI, and 125 had both antibodies negative. AMH and AFC were compared between groups. Subanalysis based on age, types of antibodies, and thyroid function markers were performed. In addition, bivariate analysis and regression models were used., Results: Overall, there was no difference in the median levels of AMH or AFC between the two groups. However, in the subgroup analysis by age, we observed a trend towards lower median levels of AMH in women over 39 years with TAI (0.9 ng/mL vs. 1.5 ng/mL, p=0.08). In a subanalysis according to antibodies, we found a significantly lower median AFC in the group with anti-Tg than in the group without this antibody (8.0 follicles vs. 11.5 follicles, p=0.036). We also found a significantly higher prevalence of anti-Tg in patients with low ovarian reserve compared to those with normal reserve (60.7% vs. 39.3%, p=0.038)., Conclusions: The ovarian reserve of women with TAI appears to be insidiously compromised over the years, with a decreased ovarian reserve in women with anti-Tg.
- Published
- 2024
- Full Text
- View/download PDF
4. Characterization of the normal fetal circulatory system of the ductus venosus using sound complexity parameters.
- Author
-
Souza ASR, Carvalho CF, Souza GFA, and Moraes RB
- Subjects
- Pregnancy, Humans, Female, Adolescent, Prospective Studies, Ultrasonography, Pregnancy Trimester, Third, Blood Flow Velocity, Fetus diagnostic imaging, Fetus blood supply, Gestational Age, Ultrasonography, Prenatal, Cardiovascular System
- Abstract
The aim of this study was to characterize the normality of the fetal circulatory system through the time between ventricular systoles of the ductus venosus in the three gestational trimesters in healthy fetuses using nonlinear methods of the complexity of the signal. A prospective cohort study was conducted at the Instituto de Medicina Integral Prof. Fernando Figueira (IMIP) from December 2019 to May 2020. Pregnant women between 11 and 14 weeks, with intrauterine pregnancy and healthy fetus were included. Patients with multiple gestation, positive screening for congenital malformation, including heart disease, and under 18 years of age were excluded. Doppler velocimetry ultrasonography of the ductus venosus was performed between the 11th and 14th weeks, 20th and 24th weeks, and 28th and 32nd weeks of gestation, and then the sound signal was extracted and segmented from the videos. To compare the means between the gestational trimesters of the approximate entropy (ApEn) and Lempel-Ziv complexity (CLZ) of the time between ventricular systoles, the Friedman test was used, with a significance level of 5%. No statistically significant difference was found between the 1st, 2nd, and 3rd trimesters regarding the mean ApEn (P=0.281) and CLZ (P=0.595) of the time between ventricular systoles of the ductus venosus. Ductus venosus systolic time was not sensitive to differentiate fetal cardiovascular dynamics between gestational trimesters. This study pioneered the characterization of cardiovascular normality by nonlinear parameters of the fetal ductus venosus in all three trimesters.
- Published
- 2023
- Full Text
- View/download PDF
5. Maternal visceral adiposity and fetal biometry in women with obesity and diabetes.
- Author
-
Lopes KRM, Alves JG, and Souza ASR
- Subjects
- Pregnancy, Female, Humans, Infant, Adiposity, Cross-Sectional Studies, Obesity complications, Biometry, Gestational Age, Obesity, Abdominal, Ultrasonography, Prenatal, Prenatal Care, Diabetes, Gestational diagnostic imaging
- Abstract
Objective: The aim of this study was to compare the correlation of maternal visceral adiposity with sonographic variables related to fetal biometry in the second trimester of pregnancy in mothers who were previously obese versus nonobese and gestational diabetic versus nondiabetic., Methods: This cross-sectional study included 583 pregnant women who received prenatal care between October 2011 and September 2013 at the Instituto de Medicina Integral Prof. Fernando Figueira, northeast of Brazil. Maternal visceral adiposity was measured by ultrasound examination at the same time as fetal biometry. Gestational age was 14.9±3.2 weeks. The correlation between maternal visceral adiposity and fetal biometric variables was evaluated using Pearson's correlation coefficient. Among the groups, the correlation coefficients were compared using Fisher's Z-test. This test was also used to evaluate the null hypothesis of correlation coefficients between pairs of variables., Results: Maternal visceral adiposity positively correlated with fetal abdominal circumference, estimated fetal weight, head circumference, femur length, and biparietal diameter in pregnant women with obesity, nonobesity, gestational diabetes, and nondiabetes, but the correlation coefficients were statistically similar among the groups., Conclusion: Maternal visceral adiposity positively correlated with fetal biometry in the second trimester of pregnancy in the same manner in pregnant women previously obese and nonobese, as well as in pregnant women with gestational diabetes and nondiabetes.
- Published
- 2023
- Full Text
- View/download PDF
6. Comparison between 200 μg and 800 μg of vaginal misoprostol for cervical ripening before operative hysteroscopy: A randomized controlled trial.
- Author
-
Maior MDCFS, Souza ASR, Souza GFA, and da Costa AAR
- Subjects
- Administration, Intravaginal, Cervical Ripening, Cervix Uteri surgery, Double-Blind Method, Female, Humans, Hysteroscopy adverse effects, Pregnancy, Preoperative Care, Misoprostol adverse effects, Oxytocics adverse effects
- Abstract
Objective: To compare between 200 and 800 μg of vaginal misoprostol for cervical ripening before operative hysteroscopy., Methods: Quadruple-blind randomized clinical trial conducted between November 2019 and September 2020 involving 76 patients undergoing cervical dilatation before surgical hysteroscopy at teaching hospitals in Pernambuco, Brazil. Women received the vaginal misoprostol dosage of 200 or 800 μg,10-12 h before operative hysteroscopy. The cervical width was the primary outcome, and secondary outcomes were patient satisfaction, adverse effects, surgical complications, and duration of cervical dilatation. Chi-square tests of association, Fisher's exact and Mann-Whitney U tests were used with an α error of <5%., Results: There was no statistical difference between the groups in the mean of the cervical width (800 μg: 6.5 ± 1.6 mm vs 200 μg: 5.8 ± 1.8 mm, P = 0.055), patient satisfaction, and surgical findings, but the duration of cervical dilatation was lower in the 800-μg group (28.16 ± 28.5 s vs 41.97 ± 31.0 s, P = 0.035). Among the adverse effects, diarrhea was more frequent in the 800-μg group with statistical difference (100% vs 0%; P = 0.01)., Conclusion: For cervical ripening, 200 μg misoprostol is equally effective with fewer adverse effects than 800 μg before operative hysteroscopy., Clinicaltrials: gov: NCT04152317. https://clinicaltrials.gov/ct2/show/NCT04152317., (© 2021 International Federation of Gynecology and Obstetrics.)
- Published
- 2022
- Full Text
- View/download PDF
7. Pregnant women infected by the Zika virus: Ultrasound findings and growth patterns of fetuses with and without microcephaly.
- Author
-
Honorato EM, Holanda SC, Mattos AGL, Souza GFA, and Souza ASR
- Subjects
- Female, Fetus, Gestational Age, Humans, Pregnancy, Pregnant Women, Retrospective Studies, Ultrasonography, Prenatal, Microcephaly diagnostic imaging, Pregnancy Complications, Infectious diagnostic imaging, Zika Virus, Zika Virus Infection diagnostic imaging
- Abstract
Objective: To compare ultrasound growth measurements of fetuses with and without microcephaly in suspected Zika virus infection., Methods: A retrospective cohort study included pregnant women with suspected Zika virus infection to evaluate 110 fetuses with and without microcephaly. The women had been admitted to the fetal medicine unit between October 2015 and August 2016. Cases of fetal microcephaly resulting from other causes were excluded. Variables evaluated were the ultrasound measurements taken at fetal biometry. The relation between each fetal biometry measurement and gestational age was analyzed using fractional polynomials in random-effects regression models. To evaluate fetal growth, curves of the mean fetal biometric parameters were constructed as a function of gestational age., Results: Mean biparietal diameter and mean head circumference increased in both groups as a function of gestational age. In the group with fetal microcephaly, mean head circumference was significantly larger in the 13th and 14th weeks of pregnancy, becoming smaller compared with the group without microcephaly from the 20th week onwards, with the difference increasing with gestational age., Conclusion: Fetal head circumference continues to increase until birth, even after a diagnosis of microcephaly, with a reduction only in the pace of growth. Growth decelerates as the pregnancy approaches term., (© 2021 International Federation of Gynecology and Obstetrics.)
- Published
- 2021
- Full Text
- View/download PDF
8. Factors associated with stress, anxiety, and depression during social distancing in Brazil.
- Author
-
Souza ASR, Souza GFA, Souza GA, Cordeiro ALN, Praciano GAF, Alves ACS, Santos ACD, Silva Junior JR, and Souza MBR
- Subjects
- Adolescent, Anxiety epidemiology, Anxiety etiology, Brazil epidemiology, Cross-Sectional Studies, Depression epidemiology, Depression etiology, Female, Humans, Physical Distancing, SARS-CoV-2, Stress, Psychological epidemiology, Stress, Psychological etiology, Surveys and Questionnaires, COVID-19, Pandemics
- Abstract
Objective: To estimate the prevalence of clinical signs and symptoms of severe/extreme stress, anxiety, and depression, as well as their associated factors, among Brazilians during social distancing., Methods: This is a cross-sectional study conducted in April/May 2020 with 3,200 Brazilians over 18 years old. Respondents' sociodemographic and clinical data were collected using an online questionnaire, which also included the 21-item Depression, Anxiety and Stress Scale (DASS-21) to assess emotional symptoms. Unadjusted and adjusted prevalence ratios and their respective 95% confidence intervals were estimated using Poisson regression models with robust variance., Results: Our results show the prevalence of severe/extreme stress was 21.5%, anxiety 19.4%, and depression 21.5%. In the final model, sociodemographic, clinical, and Covid-19-related factors were associated with severe/extreme stress, anxiety, and depression in Brazilians during social distancing due to the Covid-19 pandemic. We found the main factors associated with severe/extreme depression to be young women, brown, single, not religious, sedentary, presenting reduced leisure activities, history of anxiety and depression, increased medication use, and Covid-19 symptoms., Conclusion: This study may help develop and systematically plan measures aimed to prevent, early identify, and properly manage clinical signs and symptoms of stress, anxiety, and depression during the Covid-19 pandemic.
- Published
- 2021
- Full Text
- View/download PDF
9. Intraoperative clonidine to prevent postoperative emergence delirium following sevoflurane anesthesia in pediatric patients: a randomized clinical trial.
- Author
-
Sousa-Júnior FA, Souza ASR, Lima LC, Santos ÍGM, Menezes LAP, Ratis PAPL, and Couceiro TCM
- Subjects
- Anesthesia Recovery Period, Anesthesia, General, Child, Clonidine, Double-Blind Method, Humans, Sevoflurane, Anesthetics, Inhalation adverse effects, Emergence Delirium chemically induced, Emergence Delirium prevention & control, Methyl Ethers adverse effects, Pharmaceutical Preparations
- Abstract
Introduction and Objective: Emergence Delirium (ED), particularly in children, is characterized by mental confusion, irritability, disorientation, and inconsolable crying. ED prolongs the time required in the Post-Anesthesia Care Unit (PACU) and increases concern and anxiety in parents. The present study aimed to determine the effectiveness and safety of low-dose clonidine in preventing ED in children receiving sevoflurane anesthesia for tonsillectomy/adenotonsillectomy., Methods: A randomized, double-blind clinical trial was conducted between November 2013 and January 2014. Sixty-two children aged 2-12 years, scheduled to undergo tonsillectomy/adenotonsillectomy, and classified as American Society of Anesthesiologists (ASA) physical status I/II were included, with 29 being randomized to receive 1 μg.kg
-1 clonidine intravenously, and 33 allocated to a control group that received no clonidine. Anesthesia was induced and maintained with sevoflurane. Children with altered state of consciousness, neurological deficit, history of allergy to dipyrone, or receiving other drugs such as preanesthetic agents were excluded from the study. The primary outcome was the presence of ED in the initial 20 minutes in the PACU according to the Pediatric Anesthesia Emergence Delirium (PAED) scale. The Chi-Square test and Fisher's two-tailed exact test were used for statistical analysis, as applicable. Significance level was set at 5%, and Risk Ratios (RR) and their 95% Confidence Intervals (95% CI) were calculated., Results: The frequency of ED was significantly decreased in the group of children who received clonidine (17.2% vs. 57.6%; RR = 0.30; 95% CI 0.13-0.70; p = 0.001). There was no difference between groups with respect to the frequency of postoperative self-harm (falls and bruises), dislodged catheters, and for most of the other adverse events evaluated., Conclusions: The use of 1 μg.kg-1 intravenous clonidine during anesthesia induction can effectively reduce the incidence of ED in children undergoing elective tonsillectomy/adenotonsillectomy under general inhalation anesthesia with sevoflurane. CLINICALTRIALS., Gov Identifier: NCT02181543., (Copyright © 2020. Published by Elsevier Editora Ltda.)- Published
- 2021
- Full Text
- View/download PDF
10. Impact of Profound Burn on the Quality of Life of Women Attended at the Referral Outpatient Clinic in the State of Pernambuco.
- Author
-
Freitas SMSM, Lima CF, Albuquerque AK, Freitas Júnior RA, Souza GFA, and Souza ASR
- Subjects
- Adult, Aged, Body Image, Brazil, Cross-Sectional Studies, Female, Humans, Middle Aged, Referral and Consultation, Ambulatory Care, Burns psychology, Burns rehabilitation, Quality of Life
- Abstract
Analyze the influence of deep-degree burns on the quality of life (QoL) of women at treatment in ambulatory after hospital discharge. A cross-sectional study was conducted at a reference public hospital for burns in Recife, Pernambuco, Brazil, from August 2017 to May 2018. Fifty adult women over 20 years old who suffered deep burns and were in outpatient rehabilitation treatment were included. The variables studied were biological, sociodemographic, and clinical. The dynamometry and goniometry tests and the instruments to verify the QV Burn-Specific Health Scale-Revised were included in the analysis. Multiple linear regression models were fitted to identify factors associated with the six domains of the QoL instrument. The results identified a greater negative influence of burns on the QoL of women when associated with the variables: dark-black skin color, low levels of education, low income, motion impairment in right upper limb and lesions less than 6 months in the face, head and neck region. It should be noticed that the overall QoL score presented a median of 92.0, a score considered high, revealing an important QoL impairment. Deep-degree burn victims had a great impact on physical, emotional, and psychological abilities, acting harmfully on their self-image and causing difficulties in the execution of their daily and professional life activities, which are reinforced by aspects such as social position, level of education, and extent and duration of injury, resulting in a low QoL., (© American Burn Association 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2020
- Full Text
- View/download PDF
11. Prenatal factors associated with fetal visceral adiposity.
- Author
-
Sena ASS, Souza ASR, Barros VO, Lima MDCP, Melo ASO, and Amorim MMR
- Subjects
- Adult, Birth Weight, Body Mass Index, Female, Fetus, Humans, Obesity, Abdominal, Pregnancy, Prospective Studies, Risk Factors, Young Adult, Adiposity
- Abstract
Objective: To assess fetal visceral adiposity and associated factors during pregnancy., Methods: Secondary analysis of prospective cohort data with 172 pairs (pregnant woman/fetus) treated at public health units. Anthropometric data, metabolic (glucose, glycated hemoglobin, insulin, insulin resistance, total cholesterol and fractions, triglycerides) measures, fetal biometry, and visceral and subcutaneous adiposity in the binomial (pregnant woman/fetus) were evaluated at the 16
th , 28th and 36th gestational weeks by ultrasonography. Pearson's correlation coefficient and multiple linear regression were used, with a significance level of 5%., Results: At the 16th week, the mean age of the pregnant women was 26.6±5.8 years and mean weight was 62.7±11.5kg; 47.0% had normal weight, 28.3% were overweight, 13.3% were underweight, and 11.2% were obese. At 36 weeks, 44.1% had inadequate gestational weight gain, 32.5% had adequate gestational weight gain, and 23.3% had excessive gestational weight gain. Fetal visceral adiposity at week 36 showed a positive correlation with maternal variables: weight (r=0.15) and body mass index (r=0.21) at the 16th ; with weight (r=0.19), body mass index (r=0.24), and gestational weight gain (r=0.21) at the 28th ; and with weight (r=0.22), body mass index (r=0.26), and gestational weight gain (r=0.21) at the 36th week. After multiple linear regression, adiposity at the 28th week remained associated with fetal variables: abdominal circumference (p<0.0001), head circumference (p=0.01), area (p<0.0001), and thigh circumference (p<0.001). At the 36th week, adiposity remained associated with the abdominal circumference of the 28th (p=0.02) and 36th weeks (p<0.001)., Conclusion: Adiposity was positively correlated with the measurements of the pregnant woman. After the multivariate analysis, the persistence of the association occurred with the abdominal circumference, a central adiposity measurement with a higher metabolic risk., (Copyright © 2019. Published by Elsevier Editora Ltda.)- Published
- 2020
- Full Text
- View/download PDF
12. Misoprostol administered sublingually at a dose of 12.5 μg versus vaginally at a dose of 25 μg for the induction of full-term labor: a randomized controlled trial.
- Author
-
Gattás DSMB, de Amorim MMR, Feitosa FEL, da Silva-Junior JR, Ribeiro LCG, Souza GFA, and Souza ASR
- Subjects
- Administration, Intravaginal, Administration, Sublingual, Adult, Brazil, Dystocia etiology, Female, Humans, Misoprostol adverse effects, Oxytocics adverse effects, Pregnancy, Treatment Outcome, Young Adult, Labor, Induced methods, Misoprostol administration & dosage, Oxytocics administration & dosage
- Abstract
Background: Labor induction is defined as any procedure that stimulates uterine contractions before labor begins spontaneously. The vaginal and oral routes of administration of misoprostol are those most used for the induction of labor in routine practice, with the recommended dose being 25 μg. Nevertheless, the sublingual route may reduce the number of vaginal examinations required, increasing patient comfort and lowering the risk of maternal and fetal infection. Based on a previous systematic review, the objective of this study was to compare the frequency of tachysystole as the main outcome measure when misoprostol is administered sublingually at the dose of 12.5 μg versus vaginally at a dose of 25 μg to induce labor in a full-term pregnancy with a live fetus., Methods: A randomized, placebo-controlled, triple-blind clinical trial was conducted at two maternity hospitals in northeastern Brazil. Two hundred patients with a full-term pregnancy, a live fetus, Bishop score ≤ 6 and an indication for induction of labor were included. Following randomization, one group received 12.5 μg misoprostol sublingually and a vaginal placebo, while the other group received a sublingual placebo and 25 μg misoprostol vaginally. The primary outcome was the frequency of tachysystole. Student's t-test, the chi-square test of association and Fisher's exact test were used, as appropriate. Risk ratios and their 95% confidence intervals were calculated., Results: The frequency of tachysystole was lower in the group using 12.5 μg misoprostol sublingually compared to the group using 25 μg misoprostol vaginally (RR = 0.15; 95%CI: 0.02-0.97; p = 0.002). Failure to achieve vaginal delivery within 12 and 24 h was similar in both groups. Sublingual administration was preferred to vaginal administration by women in both groups; however, the difference was not statistically significant., Conclusion: The effectiveness of labor induction with low-dose sublingual misoprostol was similar to that achieved with vaginal administration of the recommended dose; however, the rate of tachysystole was lower in the sublingual group, and this route of administration may prove a safe alternative., Trial Registration: Registration number: NCT01406392, ClinicalTrials.gov. Date of registration: August 1, 2011.
- Published
- 2020
- Full Text
- View/download PDF
13. Effectiveness of an oral versus sublingual loading dose of nifedipine for tocolysis.
- Author
-
Leal-Júnior CC, Amorim MMR, Souza GFA, Lima AKS, and Souza ASR
- Subjects
- Administration, Oral, Administration, Sublingual, Adult, Brazil, Female, Gestational Age, Humans, Pregnancy, Premature Birth prevention & control, Time Factors, Nifedipine administration & dosage, Obstetric Labor, Premature drug therapy, Tocolysis methods, Tocolytic Agents administration & dosage
- Abstract
Objective: To determine the effectiveness of an oral versus sublingual loading dose of nifedipine for tocolysis., Methods: An open, randomized clinical trial conducted between March 1, 2013, and April 31, 2014. Participants were pregnant women with a diagnosis of premature labor, single live fetus, topical pregnancy, gestational age 24-36 weeks, normal fetal vitality, cervical dilatation less than or equal to 4 cm, cervical effacement less than or equal to 80%, and intact amniotic membranes. They were randomized into two groups, oral and sublingual nifedipine, 20 mg loading dose, repeated every 30 minutes (maximum dose of 60 mg). The primary endpoint was the time until tocolysis and the secondary endpoints were the effectiveness of tocolysis within 90 minutes, 12 hours, and 48 hours; premature delivery within 48 hours; and maternal hemodynamic parameters and side effects., Results: There were 80 patients randomized to oral (n=40) and sublingual (n=40) nifedipine. The time required for tocolysis was significantly less with sublingual nifedipine (160 minutes vs 340 minutes; P=0.0003). Sublingual nifedipine was also more successful than oral nifedipine at inhibiting premature labor within 90 minutes (n=8 [20.0%] vs n=1 [2.5%], P=0.014). There was no statistically significant difference between the groups for the other secondary endpoints., Conclusion: Compared with oral administration, a sublingual loading dose of nifedipine resulted in faster tocolysis in patients with premature labor. Brazilian Clinical Trials Registry (ReBEC): U1111-11566186., (© 2019 International Federation of Gynecology and Obstetrics.)
- Published
- 2020
- Full Text
- View/download PDF
14. Visceral Adipose Tissue Depth in Early Pregnancy and Gestational Diabetes Mellitus - a Cohort Study.
- Author
-
Alves JG, Souza ASR, Figueiroa JN, de Araújo CAL, Guimarães A, and Ray JG
- Subjects
- Adult, Age Factors, Body Mass Index, Cohort Studies, Diabetes, Gestational blood, Diabetes, Gestational diagnosis, Diabetes, Gestational physiopathology, Female, Follow-Up Studies, Glucose Tolerance Test, Humans, Intra-Abdominal Fat physiology, Predictive Value of Tests, Pregnancy, Pregnancy Trimester, First, Prospective Studies, ROC Curve, Risk Assessment methods, Ultrasonography, Young Adult, Adiposity physiology, Diabetes, Gestational epidemiology, Intra-Abdominal Fat diagnostic imaging
- Abstract
Some studies have suggested that abdominal visceral adipose tissue depth (VAD) measured by ultrasound in early pregnancy, may predict the future onset of gestational diabetes mellitus (GDM). Wheter this is true, independent of pre-pregnancy body mass index (BMI), has been debated, leading the current study. A prospective cohort study was completed, in which VAD was measured at around 14 weeks' gestation. GDM was later assessed by an oral glucose tolerance test at 24 to 28 weeks, according to the IADPSG criteria. Logistic regression analysis and receiver operating curve (ROC) analysis were used to estimate the predictive value of VAD, above and beyond pre-pregnancy BMI. 627 pregnant women were enrolled, and 518 completed the study. VAD was measured at a mean of 14.4 weeks' gestation. 87 women (16.8%) subsequently developed GDM. The unadjusted odds ratio (OR) for developing GDM was 1.99 (95% CI 1.59-2.46) per 1-cm increase in VAD. After adjusting for maternal BMI and age, the OR was 2.00 (95% CI 1.61 to 2.50). The ROC under the curve for developing GDM was higher for VAD (0.70, 95% CI 0.63 to 0.75) than for pre-pregnancy BMI (0.57 95% CI 0.50 to 0.64) (p < 0.001). In conclusion, higher VAD may better predict GDM than pre-pregnancy BMI.
- Published
- 2020
- Full Text
- View/download PDF
15. Anal prevalence of HPV in women with pre-malignant lesion or cancer in the cervix and anal canal simultaneously: cross-sectional study.
- Author
-
Heráclio SA, de Souza ASR, Silveira RK, Torres LC, Nunes MJG, and Amorim MMR
- Subjects
- Adult, Cross-Sectional Studies, Female, Humans, Middle Aged, Papillomaviridae isolation & purification, Papillomavirus Infections epidemiology, Papillomavirus Infections virology, Prevalence, Prospective Studies, Risk Factors, Squamous Intraepithelial Lesions of the Cervix epidemiology, Squamous Intraepithelial Lesions of the Cervix pathology, Anal Canal pathology, Cervix Uteri pathology, Papillomavirus Infections diagnosis, Squamous Intraepithelial Lesions of the Cervix diagnosis
- Abstract
Objective: To determine the prevalence of anal HPV genotypes and associated factors in women with pre-malignant lesion or cancer in the cervix and anal canal., Methods: A prospective, cross-sectional study analyzed DNA samples taken from women with cervical pre-malignant lesions or cancer to identify anal HPV by polymerase chain reaction (PCR). The prevalence of high-risk HPV (HR-HPV) in women with intraepithelial neoplasia and anal cancer was calculated; sociodemographic and clinical risk factors were identified using multivariate analysis., Results: A total of 152 patients were included (mean age 37.8 ± 10.01 years), of whom 101 (66.4%) had anal HR-HPV. Fourteen different anal HPV types were identified. HPV 16 and 18 were found in 30 (52.6%) anal high-grade squamous intraepithelial lesions (HSIL), and HPV 31 and 33 in 21 (36.8%) lesions. In the logistic regression analysis, the factors that remained associated with HR-HPV types were: an anal histopathology report of HSIL or invasive carcinoma (odds ratio [OR] 8.96, 95% confidence interval [CI] 3.40-23.57; P<0.0001) and alcohol consumption (OR 2.20, 95% CI 1.01-4.80; P=0.04)., Conclusion: Prevalence of HR-HPV is high in the anal canal of women with cervical and anal pre-malignant lesions simultaneously or cancer of the cervix and/or anal canal. HPV 16, 31, 33, and 18 were the four major genotypes identified., (© 2019 International Federation of Gynecology and Obstetrics.)
- Published
- 2019
- Full Text
- View/download PDF
16. Is Moderate Intensity Exercise during Pregnancy Safe for the Fetus? An Open Clinical Trial.
- Author
-
Melo ASO, Silva JLPE, Melo FO, Barros ES, Santos HL, Amorim MMR, and Souza ASR
- Subjects
- Adolescent, Adult, Blood Pressure physiology, Cardiotocography, Female, Humans, Pregnancy Trimester, Third physiology, Walking physiology, Young Adult, Exercise physiology, Fetus physiology, Heart Rate, Fetal physiology, Pregnancy physiology, Safety
- Abstract
Objetivo: Determinar o efeito da caminhada em esteira sobre a frequência cardíaca materna (FCM) e parâmetros cardiotocográficos (batimentos cardiofetais basais [BCFs], movimentos ativos fetais [MAFs], número de acelerações e desacelerações e variabilidade de curta [STV] e longa [LTV] duração da frequência cardíaca fetal) em gestantes na 36
a semana. MéTODOS: Foi realizado um ensaio clínico não randomizado e aberto com 88 gestantes saudáveis submetidas a caminhada de moderada intensidade na esteira e a cardiotocografia computadoriza em 3 momentos de 20 minutos (antes, durante e após a caminhada)., Resultados: A média dos BCFs diminuiu durante a caminhada, retornando a níveis prévios (antes: 137 bpm; durante: 98 bpm; após: 140 bpm; p < 0,001), com bradicardia ocorrendo em 56% dos fetos nos primeiros 10 minutos do exercício, e em 47% após 20 minutos. A bradicardia fetal não foi observada em outros momentos (antes ou depois). As médias da STV e da LTV foram 7,9, 17,0 e 8,0 milissegundos ( p < 0,001) e 7,6, 10,7 e 7,6 bpm ( p = 0,002) antes, durante e após a caminhada, respectivamente. A média dos números dos MAFs em 1 hora foi 29,9, 22,2 e 45,5, respectivamente, nos três momentos ( p < 0,001). Nas mulheres com sobrepeso/obesidade, a média da FCM foi menor ( p = 0,02). Após a análise de regressão logística, duas variáveis permaneceram significativamente associadas a bradicardia: aptidão maternal na 28a semana de gravidez (efeito protetor) e peso materno (aumento do risco). CONCLUSãO: Em fetos saudáveis, o exercício físico mostrou-se seguro, uma vez que, embora os BCFs e os MAFs diminuam durante a caminhada na esteira, foi observado um aumento da SVT e da LTV., Competing Interests: The authors have no conflicts of interests to declare., (Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil.)- Published
- 2019
- Full Text
- View/download PDF
17. Effect of spironolactone on the progression of coronary calcification in peritoneal dialysis patients: a pilot study.
- Author
-
Gueiros APS, Gueiros JEB, Nóbrega KT, Calado EB, Matta MCD, Torres LC, Souza ASR, Casarini DE, and Carvalho AB
- Subjects
- Aged, Calcium blood, Cholesterol, LDL blood, Female, Follow-Up Studies, Humans, Lost to Follow-Up, Male, Middle Aged, Mineralocorticoid Receptor Antagonists administration & dosage, Pilot Projects, Prospective Studies, Renal Insufficiency, Chronic therapy, Serum Albumin, Human analysis, Spironolactone administration & dosage, Tomography Scanners, X-Ray Computed, Treatment Outcome, Vascular Calcification diagnostic imaging, Vascular Calcification pathology, Disease Progression, Mineralocorticoid Receptor Antagonists therapeutic use, Peritoneal Dialysis, Spironolactone therapeutic use, Vascular Calcification blood, Vascular Calcification drug therapy
- Abstract
Introduction: There is evidence that aldosterone plays a role in the pathogenesis of vascular calcification. The aim of this study was to evaluate the effect of spironolactone, a mineralocorticoid receptor antagonist, on the progression of coronary calcification (CC) in peritoneal dialysis patients and to identify the factors involved in this progression., Methods: Thirty-three patients with a coronary calcium score (CCS) ≥ 30, detected through multi-detector computed tomography (MDCT) and expressed in Agatston units, were randomly assigned to a group receiving 25mg spironolactone per day for 12 months (spironolactone group) and a control group not receiving this drug. The primary outcome was a percentage change in CCS from baseline to end of the study (relative progression), when a further MDCT was conducted. Patients who had progression of CC were compared with those who did not progress., Results: Sixteen patients, seven in the spironolactone group and nine in the control group, concluded the study. The relative progression of the CCS was similar in both groups, 17.2% and 27.5% in the spironolactone and control groups respectively. Fifty-seven percent of the treated patients and 67% of those in the control group presented progression in the CC scores (p = 0.697). Progressor patients differed from non-progressors because they presented higher levels of calcium and low-density lipoprotein cholesterol and lower levels of albumin., Conclusion: In peritoneal dialysis patients, spironolactone did not attenuate the progression of CC. However, large-scale studies are needed to confirm this observation. Disorders of mineral metabolism and dyslipidemia are involved in the progression of CC.
- Published
- 2019
- Full Text
- View/download PDF
18. Misoprostol administered sublingually at a dose of 12.5 μg versus vaginally at a dose of 25 μg for the induction of full-term labor: a randomized controlled trial protocol.
- Author
-
Gattás DSMB, da Silva Junior JR, Souza ASR, Feitosa FE, and de Amorim MMR
- Subjects
- Administration, Intravaginal, Administration, Sublingual, Adult, Female, Humans, Pregnancy, Pregnancy Outcome, Labor, Induced methods, Misoprostol administration & dosage, Oxytocics administration & dosage
- Abstract
Background: Various methods are currently used for the induction of labor. Nevertheless, the most effective method with the fewest side effects remains to be established. Misoprostol, administered vaginally, has been routinely used for this purpose; however, other forms of administration are being proposed, including the use of sublingual tablets. No studies have yet compared the effectiveness and safety of 12.5-μg misoprostol administered sublingually compared to a 25-μg vaginal dose of the drug for the induction of labor., Methods: A triple-blind, multicenter, placebo-controlled, randomized clinical trial will be conducted in Brazil at the Instituto de Medicina Integral Prof. Fernando Figueira and at the Assis Chateaubriand Maternity Teaching Hospital of the Federal University of Ceará. A total of 140 patients with full-term pregnancies, a live fetus, a Bishop score ≤ 6 and a recommendation of induction of labor will be randomized to one of two groups. One group will receive 12.5-μg sublingual tablets of misoprostol and placebo vaginal tablets, while the other group will receive placebo sublingual tablets and vaginal tablets containing 25 μg of misoprostol. The principal endpoint is the rate of tachysystole. The secondary endpoints are vaginal delivery within 24 h of induction, uterine hyperstimulation, Cesarean section, severe neonatal morbidity or perinatal death, severe maternal morbidity or maternal death, and maternal preference regarding the route of administration of the drug. Student's t-test, and the chi-square test of association or Fisher's exact test, as appropriate, will be used in the data analysis. Risk ratios and their respective 95% confidence intervals will be calculated., Discussion: Misoprostol has been identified as a safe, inexpensive, easily administered option for the induction of labor, with satisfactory results. An experimental study has shown that misoprostol administered sublingually at a dose of 25 μg appears to be effective and is associated with greater maternal satisfaction when labor is induced in women with an unfavorable cervix. Nevertheless, the rate of tachysystole remains high; therefore, further studies are required to determine the ideal dose and the ideal interval of time between doses., Trial Registration: ClinicalTrial.gov, NCT01406392 .
- Published
- 2018
- Full Text
- View/download PDF
19. Cross-sectional study of anal intraepithelial lesions in women with cervical neoplasia without HIV.
- Author
-
Heráclio SA, de Souza ASR, de Souza PRE, Katz L, Lima Junior SF, and Amorim MMR
- Subjects
- Adult, Anus Neoplasms etiology, Anus Neoplasms virology, Brazil epidemiology, Carcinoma in Situ etiology, Carcinoma in Situ virology, Cross-Sectional Studies, Female, HIV Seronegativity, Humans, Middle Aged, Neoplasm Grading, Papillomaviridae isolation & purification, Papillomavirus Infections epidemiology, Papillomavirus Infections virology, Pregnancy, Prevalence, Risk Factors, Uterine Cervical Neoplasms etiology, Uterine Cervical Neoplasms virology, Young Adult, Uterine Cervical Dysplasia etiology, Anus Neoplasms epidemiology, Carcinoma in Situ epidemiology, Uterine Cervical Neoplasms epidemiology, Uterine Cervical Dysplasia epidemiology
- Abstract
Objective: To evaluate the prevalence of anal intraepithelial lesions and associated risk factors in women with cervical neoplasia., Methods: The present cross-sectional study enrolled patients with intraepithelial or invasive cervical neoplasia who had been referred to the lower genital tract pathology outpatient department of the Instituto de Medicina Integral Prof. Fernando Figueira, Recife, Brazil, between December 1, 2008, and December 31, 2009; patients with HIV infections were excluded. All participants underwent anal cytology and high-resolution anoscopy; sociodemographic and clinical risk factors were identified using multivariate analysis., Results: There were 324 patients included and 37 (11.4%) had anal intraepithelial neoplasia. Factors associated with anal intraepithelial neoplasia in the multivariate analysis were being older than 35 years of age (P=0.002), having completed no more than 4 years of education (P=0.012), anomalous anal cytology (P=0.003), and anomalous high-resolution anoscopy findings (P<0.001); subclinical HPV lesions on vulvoscopy (P=0.057) were not associated with anal intraepithelial neoplasia., Conclusion: The prevalence of anal intraepithelial neoplasia was high among patients with cervical neoplasia who did not have HIV, particularly patients older than 35 years., (© 2017 International Federation of Gynecology and Obstetrics.)
- Published
- 2018
- Full Text
- View/download PDF
20. Planned caesarean section versus planned vaginal birth for severe pre-eclampsia.
- Author
-
Amorim MM, Souza ASR, and Katz L
- Subjects
- Female, Humans, Pregnancy, Cesarean Section, Delivery, Obstetric, Parturition, Pre-Eclampsia
- Abstract
Background: Pre-eclampsia is a very frequent complication of pregnancy, and anticipation of birth is often necessary. However, the best mode of giving birth remains to be established, although observational studies suggest better maternal and perinatal outcomes with vaginal birth., Objectives: To assess the effects of a policy of planned caesarean section versus planned vaginal birth for women with severe pre-eclampsia on mortality and morbidity for mother and baby., Search Methods: We searched Cochrane Pregnancy and Childbirth's Trials Register, ClinicalTrials.gov, the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (6 September 2017) and reference lists of retrieved studies., Selection Criteria: We planned to include all randomised trials of planned caesarean section versus planned vaginal birth for pregnant women with severe pre-eclampsia. Quasi-randomised and non-randomised studies are not eligible for inclusion in this review.The focus of this review is severe pre-eclampsia; studies of planned caesarean section versus planned vaginal birth in pregnant women with eclampsia are not eligible for inclusion., Data Collection and Analysis: We identified no studies that met the inclusion criteria. We excluded two studies., Main Results: There are no included studies in this review., Authors' Conclusions: There is a lack of robust evidence from randomised controlled trials that can inform practice regarding planned caesarean section versus planned vaginal birth for women with severe pre-eclampsia. There is a need for high-quality randomised controlled trials to assess the short- and long-term effects of caesarean section and vaginal birth for these women and their babies.
- Published
- 2017
- Full Text
- View/download PDF
21. Correlation between pre-pregnancy body mass index and maternal visceral adiposity with fetal biometry during the second trimester.
- Author
-
Lopes KRM, Souza ASR, Figueiroa JN, and Alves JGB
- Subjects
- Adiposity, Adult, Biometry, Cross-Sectional Studies, Female, Fetal Weight, Humans, Prenatal Care, Retrospective Studies, Body Mass Index, Fetus diagnostic imaging, Intra-Abdominal Fat diagnostic imaging, Pregnancy physiology, Pregnancy Trimester, Second physiology, Ultrasonography, Prenatal
- Abstract
Objective: To determine the correlation between pre-pregnancy body mass index (BMI) and maternal visceral adiposity with fetal biometry during the second trimester., Methods: A cross-sectional observational study was conducted among pregnant women who received prenatal care at a center in Recife, Brazil, between October 3, 2011, and September 27, 2013. Pre-pregnancy BMI was determined at the first prenatal care visit. Maternal visceral adiposity and fetal biometry were measured at the same ultrasonography session. The associations between maternal and fetal variables were evaluated using the Pearson correlation coefficient (R). The Student t test was used to test the null hypothesis of adjusted correlation coefficients., Results: Overall, 740 women were included. No correlation was found between pre-pregnancy BMI and any of the fetal biometric variables assessed. By contrast, maternal visceral adiposity positively correlated with fetal abdominal circumference (R=0.529), estimated fetal weight (R=0.524), head circumference (R=0.521), femur length (R=0.521), and biparietal diameter (R=0.524; P<0.001 for all fetal variables). These findings remained statistically significant after controlling for pregnancy length., Conclusion: Maternal visceral adiposity, but not pre-pregnancy BMI, positively correlated with fetal biometry during the second trimester., (© 2017 International Federation of Gynecology and Obstetrics.)
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.